Pharmaceutical Technology

JANUARY 15, 2024

The acquired programme consists of antibiotics against gram-negative bacteria, including multidrug-resistant strains.

Bacteria 147

Bacteria 147

Pharma Times

JANUARY 15, 2024

CellVoyant’s platform combines AI with live cell imaging

131

131

Pharmaceutical Technology

JANUARY 15, 2024

MSD’s blockbuster immunotherapy, set to lose patent protection in 2028, secures third FDA approval in cervical cancer.

FDA Approval 147

FDA Approval 147

Pharma Times

JANUARY 15, 2024

Companies collaborate to launch walk-in pain clinic

Pharmacy 127

Pharmacy 127

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

JANUARY 15, 2024

If new treatments are shown to maintain weight loss, they will become game changers within the obesity space.

147

147

pharmaphorum

JANUARY 15, 2024

Researchers at the University of Cambridge and Pfizer have developed an AI-powered approach to make it easier to design and make pharma molecules

Development 119

Development Research 119

FDA Law Blog

JANUARY 15, 2024

By David B. Clissold & Sara W. Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. To quote the Fifth Circuit: “It was the regulatory equivalent of Romeo sending Mercutio on a wild goose chase—and then admitting there never was a goose while denying he even suggested the chase.

Production 115

Production Manufacturing Marketing Regulation 115

pharmaphorum

JANUARY 15, 2024

MSD’s Keytruda has been cleared by the FDA as the first PD-1 inhibitor for newly diagnosed cervical cancer patients with less severe disease

115

115

BioPharma Reporter

JANUARY 15, 2024

CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a Â7.6 million seed round.

Development 108

Development 108

pharmaphorum

JANUARY 15, 2024

True innovation in life sciences is only possible through a connected, pan-European approach Mike.

Life Science 111

Life Science 111

Advertisement

Clinical Supply

JAMA Internal Medicine

JANUARY 15, 2024

This cohort study examines the whether there were changes in opioid prescribing and opioid-related health outcomes after implementation of British Columbia’s Safer Opioid Supply policy.

108

108

pharmaphorum

JANUARY 15, 2024

Speculation about a takeover play for Cytokinetics isn’t going away, with Amgen the latest company to be linked to the company and its highly-anticipated cardiovascular drug aficamten.

Drugs 109

Drugs 109

Pharmaceutical Commerce

JANUARY 15, 2024

FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.

FDA Approval 107

FDA Approval Drugs 107

pharmaphorum

JANUARY 15, 2024

Santhera’s new treatment for Duchenne muscular dystrophy Agamree has been launched in its first market, Germany, following its EU approval last month.

Drugs 105

Drugs Marketing 105

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

JANUARY 15, 2024

PCM Trials, a Denver, USA based leader in providing mobile research nurses for decentralized clinical trials, today announced the acquisition of Clinical Trial Service (CTS).

Clinical Trials 100

Clinical Trials Clinical Trials Trials Nurses 100

pharmaphorum

JANUARY 15, 2024

Orion buys stake in LegoChem amid pivot to cancer and pain Phil.

105

105

Outsourcing Pharma

JANUARY 15, 2024

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

Contract Manufacturing 85

Contract Manufacturing Manufacturing 85

pharmaphorum

JANUARY 15, 2024

Germany’s IG BCE trade union has pushed back against any break-up of Bayer, claiming it could put thousands of domestic jobs at risk

105

105

Advertisement

Clinical Supply

Outsourcing Pharma

JANUARY 15, 2024

SGD Pharma has announced its goal to become the global market leader in primary pharmaceutical glass packaging.

Packaging 85

Packaging Packaging Manufacturing Marketing 85

XTalks

JANUARY 15, 2024

As far as condiments go, few brands have managed to capture the hearts and taste buds of food enthusiasts quite like TRUFF. Known for infusing the luxury of truffles into everyday pantry staples, TRUFF recently unveiled its newest creation: the TRUFF Jalapeño Lime Hot Sauce. This vibrant green sauce, distinct in both flavor and color, marks a bold new chapter in the company’s innovative journey.

Branding 64

Branding Packaging Packaging Marketing 64

Outsourcing Pharma

JANUARY 15, 2024

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

Contract Manufacturing 80

Contract Manufacturing Manufacturing 80

Drug Patent Watch

JANUARY 15, 2024

This chart shows the pharmaceutical companies with the most injectable dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most injectable dosed drugs… The post Which pharmaceutical companies have the most injectable dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs 59

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Outsourcing Pharma

JANUARY 15, 2024

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

Contract Manufacturing 78

Contract Manufacturing Manufacturing 78

Drug Patent Watch

JANUARY 15, 2024

Annual Drug Patent Expirations for PROLENSA Prolensa is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from two suppliers. There are nine… The post New patent expiration for Bausch And drug PROLENSA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Outsourcing Pharma

JANUARY 15, 2024

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

Contract Manufacturing 59

Contract Manufacturing Manufacturing 59

Drug Patent Watch

JANUARY 15, 2024

Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are six patents protecting… The post New patent for Bioxcel drug IGALMI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

BioPharma Reporter

JANUARY 15, 2024

In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion.

Drugs 59

Drugs Development 59

Drug Patent Watch

JANUARY 15, 2024

Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug. This drug has… The post New patent expiration for Btcp Pharma drug LAZANDA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

pharmaphorum

JANUARY 15, 2024

Artificial intelligence (AI) is transforming the healthcare industry, particularly in decision-making and therapeutic advancements. Learn how AI will revolutionise healthcare and impact future decision-making processes in this informative article.

59

59

Drug Patent Watch

JANUARY 15, 2024

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent for Sumitomo Pharma drug ORGOVYX appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials